Skip to content
PubMed This is a summary of 57 peer-reviewed journal articles Updated
Neurology

Macrocephaly-spastic paraplegia-dysmorphism syndrome (KIDINS220-related disorder): A Patient Guide

At a Glance

KIDINS220-related disorder (SINO syndrome) is a rare genetic condition affecting brain and nerve development. Children may have a large head, low muscle tone that may progress to leg stiffness, vision differences, and developmental delays, so care is individualized and often multidisciplinary.

Macrocephaly-spastic paraplegia-dysmorphism syndrome, increasingly known as a KIDINS220-related disorder or SINO syndrome, is an exceptionally rare genetic condition that shapes how a child’s brain and nervous system develop. At its core, the condition is caused by changes in the KIDINS220 gene, which provides the blueprint for a protein essential for the survival and communication of nerve cells. When this gene does not function as expected, it disrupts the “scaffolding” of the developing brain, leading to a unique combination of physical, visual, and cognitive features that typically emerge in early childhood [1][2].

The condition is characterized by a spectrum of neurological changes that are variable. Many children initially present with low muscle tone, or hypotonia, which can gradually transition into stiffness, known as spasticity, particularly in the legs. This journey is sometimes accompanied by macrocephaly (a larger-than-average head size) and enlarged fluid spaces of the brain (ventriculomegaly). Because the KIDINS220 protein is so vital to the nervous system, children may also experience challenges with vision—such as involuntary eye movements—and varying degrees of learning and developmental delays [3][4]. It is important to know that enlarged ventricles may be stable and asymptomatic, and do not automatically mean dangerous pressure.

Living with this diagnosis means navigating a path that is still being mapped by the medical community. Because there are so few cases globally, care is centered on a proactive, multidisciplinary approach that brings together experts in neurology, genetics, vision, and physical rehabilitation. The most critical aspects of management involve supporting a child’s mobility through physical therapy, monitoring for structural brain changes, and addressing nutritional needs to support long-term metabolic health [5][6]. Note that management recommendations are individualized and not a substitute for the child’s clinicians.

While the rarity of the condition can feel isolating, it also means that every child’s progress contributes to a growing global understanding of the disorder. Families often find that focusing on functional, everyday goals—such as improving communication or enhancing mobility—provides a clear sense of direction. By building a dedicated care team and staying alert to your child’s unique needs, you can create an environment that fosters their growth and prioritizes their quality of life as they move through different stages of development [7][8].

Common questions in this guide

What is KIDINS220-related disorder, also called SINO syndrome?
It is a very rare genetic condition caused by a change in the KIDINS220 gene, which helps nerve cells survive and communicate. The change can affect how the brain and nervous system develop, and features vary from child to child.
What signs and symptoms can a child with this condition have?
Children may have low muscle tone early in life that can later become stiffness, especially in the legs. Other possible features include a larger-than-average head, enlarged fluid spaces in the brain, involuntary eye movements or other vision challenges, and developmental or learning delays.
Does ventriculomegaly always mean there is dangerous pressure in the brain?
No. Enlarged fluid spaces can remain stable and cause no symptoms, so ventriculomegaly does not automatically mean that pressure is dangerously high. The child’s clinicians can interpret brain imaging alongside symptoms and development.
What kind of care is usually needed for KIDINS220-related disorder?
Care is individualized and often involves neurology, genetics, vision care, and physical rehabilitation. Physical therapy may support mobility, while clinicians monitor brain structure and address nutrition and developmental or communication needs.
How can families support a child’s progress and quality of life?
Families can work with the care team on practical goals such as mobility, communication, learning, and daily activities. Coordinating specialists through a lead clinician or medical home can help keep recommendations organized as needs change.

Get notified when new evidence is published on Macrocephaly-spastic paraplegia-dysmorphism syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Refining the phenotype of SINO syndrome: A comprehensive cohort report of 14 novel cases.

    Alstrup M, Cesca F, Krawczun-Rygmaczewska A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(11)):101219 doi:10.1016/j.gim.2024.101219.

    PMID: 39033379
  2. 2

    Heterozygous KIDINS220/ARMS nonsense variants cause spastic paraplegia, intellectual disability, nystagmus, and obesity.

    Josifova DJ, Monroe GR, Tessadori F, et al.

    Human molecular genetics 2016; (25(11)):2158-2167 doi:10.1093/hmg/ddw082.

    PMID: 27005418
  3. 3

    A Novel KIDINS220 Pathogenic Variant Associated with the Syndromic Spastic Paraplegia SINO: An Expansion of the Brain Malformation Spectrum and a Literature Review.

    Bonati MT, Baldoli C, Taurino J, et al.

    Genes 2024; (15(9)) doi:10.3390/genes15091190.

    PMID: 39336781
  4. 4

    Novel autosomal recessive SINO syndrome-associated KIDINS220 variants provide insight into the genotype-phenotype correlation.

    Yang W, Wang S, Huo X, et al.

    Heliyon 2024; (10(17)):e37355 doi:10.1016/j.heliyon.2024.e37355.

    PMID: 39296002
  5. 5

    Consensus clinical management guidelines for Alström syndrome.

    Tahani N, Maffei P, Dollfus H, et al.

    Orphanet journal of rare diseases 2020; (15(1)):253 doi:10.1186/s13023-020-01468-8.

    PMID: 32958032
  6. 6

    Physiotherapy strategies for functional improvement in a child with complicated hereditary spastic paraplegia: 1-year follow-up of a case report using a changing criterion design.

    Choi JY, Oh DW, Son SM, Kim CJ

    Physiotherapy research international : the journal for researchers and clinicians in physical therapy 2023; e2006 doi:10.1002/pri.2006.

    PMID: 37058697
  7. 7

    Social Media Use Among Parents and Caregivers of Children With Rare Genetic Diseases: Scoping Review.

    Davis C, Bogaert L, Powell J, Low K

    Journal of medical Internet research 2025; (27()):e77087 doi:10.2196/77087.

    PMID: 41313807
  8. 8

    High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease.

    Van Groenendael S, Giacovazzi L, Davison F, et al.

    Orphanet journal of rare diseases 2015; (10()):149 doi:10.1186/s13023-015-0366-y.

    PMID: 26603037

This page explains KIDINS220-related disorder for educational purposes and does not replace medical advice. Your child’s neurologist, geneticist, and other clinicians should guide individualized care.